Is interferon-a an active agent in Castleman's disease?
dc.contributor.author | Pavlidis, Nicholas | en |
dc.contributor.author | Briassoulis, E. Ch | en |
dc.contributor.author | Klouvas, G. D. | en |
dc.contributor.author | Bai, M. C. | en |
dc.creator | Pavlidis, Nicholas | en |
dc.creator | Briassoulis, E. Ch | en |
dc.creator | Klouvas, G. D. | en |
dc.creator | Bai, M. C. | en |
dc.date.accessioned | 2018-06-22T09:54:19Z | |
dc.date.available | 2018-06-22T09:54:19Z | |
dc.date.issued | 1992 | |
dc.identifier.uri | https://gnosis.library.ucy.ac.cy/handle/7/42301 | |
dc.language.iso | eng | en |
dc.source | Annals of Oncology | en |
dc.subject | Article | en |
dc.subject | Human | en |
dc.subject | Prednisone | en |
dc.subject | Vincristine | en |
dc.subject | Adult | en |
dc.subject | Female | en |
dc.subject | Intravenous drug administration | en |
dc.subject | Subcutaneous drug administration | en |
dc.subject | Case report | en |
dc.subject | Chlorambucil | en |
dc.subject | Alpha2b interferon | en |
dc.subject | Angiofollicular lymph node hyperplasia | en |
dc.subject | Antipyretic agent | en |
dc.title | Is interferon-a an active agent in Castleman's disease? | en |
dc.type | info:eu-repo/semantics/article | |
dc.identifier.doi | 10.1093/oxfordjournals.annonc.a058082 | |
dc.description.volume | 3 | |
dc.description.issue | 1 | |
dc.description.startingpage | 85 | |
dc.description.endingpage | 86 | |
dc.author.faculty | Ιατρική Σχολή / Medical School | |
dc.author.department | Ιατρική Σχολή / Medical School | |
dc.type.uhtype | Article | en |
dc.contributor.orcid | Pavlidis, Nicholas [0000-0002-2195-9961] | |
dc.gnosis.orcid | 0000-0002-2195-9961 |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |